Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
9.38
+0.01 (0.11%)
Jun 6, 2025, 3:04 PM CST
SHE:002332 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 9,279 | 9,833 | 12,632 | 11,178 | 13,058 | 13,216 | Upgrade
|
Market Cap Growth | 6.62% | -22.16% | 13.01% | -14.39% | -1.20% | 46.14% | Upgrade
|
Enterprise Value | 8,019 | 8,693 | 11,208 | 10,046 | 12,828 | 13,835 | Upgrade
|
Last Close Price | 9.38 | 9.62 | 12.06 | 10.46 | 12.02 | 12.03 | Upgrade
|
PE Ratio | 23.88 | 24.76 | 22.43 | 14.92 | 21.08 | 26.20 | Upgrade
|
Forward PE | 15.07 | 12.86 | 17.64 | 14.26 | 16.42 | 19.94 | Upgrade
|
PS Ratio | 2.34 | 2.46 | 3.06 | 2.55 | 3.00 | 3.29 | Upgrade
|
PB Ratio | 1.53 | 1.67 | 2.17 | 2.03 | 2.64 | 2.88 | Upgrade
|
P/TBV Ratio | 1.76 | 1.92 | 2.52 | 2.38 | 3.19 | 3.63 | Upgrade
|
P/FCF Ratio | 131.43 | 51.46 | 35.01 | 34.21 | 31.90 | 19.69 | Upgrade
|
P/OCF Ratio | 30.12 | 24.67 | 21.21 | 18.35 | 19.85 | 16.75 | Upgrade
|
EV/Sales Ratio | 2.02 | 2.17 | 2.72 | 2.29 | 2.94 | 3.44 | Upgrade
|
EV/EBITDA Ratio | 9.48 | 10.41 | 13.73 | 11.60 | 14.97 | 16.93 | Upgrade
|
EV/EBIT Ratio | 12.94 | 14.08 | 18.53 | 14.80 | 19.06 | 21.62 | Upgrade
|
EV/FCF Ratio | 113.59 | 45.50 | 31.06 | 30.75 | 31.34 | 20.62 | Upgrade
|
Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.06 | 0.15 | 0.26 | Upgrade
|
Debt / EBITDA Ratio | 0.07 | 0.07 | 0.27 | 0.40 | 0.86 | 1.44 | Upgrade
|
Debt / FCF Ratio | 0.90 | 0.31 | 0.61 | 1.05 | 1.81 | 1.76 | Upgrade
|
Asset Turnover | 0.56 | 0.57 | 0.60 | 0.65 | 0.64 | 0.64 | Upgrade
|
Inventory Turnover | 1.92 | 1.88 | 2.17 | 2.07 | 2.26 | 2.58 | Upgrade
|
Quick Ratio | 3.27 | 2.94 | 2.29 | 2.58 | 1.83 | 1.78 | Upgrade
|
Current Ratio | 4.64 | 4.20 | 3.25 | 3.54 | 2.57 | 2.32 | Upgrade
|
Return on Equity (ROE) | 6.34% | 6.83% | 9.92% | 14.29% | 13.04% | 13.85% | Upgrade
|
Return on Assets (ROA) | 5.41% | 5.52% | 5.51% | 6.30% | 6.20% | 6.32% | Upgrade
|
Return on Capital (ROIC) | 6.30% | 6.43% | 6.35% | 7.35% | 7.35% | 7.55% | Upgrade
|
Return on Capital Employed (ROCE) | 9.70% | 9.90% | 10.20% | 11.80% | 12.60% | 12.30% | Upgrade
|
Earnings Yield | 4.20% | 4.04% | 4.46% | 6.70% | 4.74% | 3.82% | Upgrade
|
FCF Yield | 0.76% | 1.94% | 2.86% | 2.92% | 3.14% | 5.08% | Upgrade
|
Dividend Yield | 3.20% | 3.12% | 2.49% | 2.87% | 1.25% | 1.25% | Upgrade
|
Payout Ratio | 76.32% | 75.08% | 53.24% | 20.58% | 27.79% | 28.22% | Upgrade
|
Buyback Yield / Dilution | -1.41% | -0.51% | 0.13% | -0.00% | -7.84% | -0.59% | Upgrade
|
Total Shareholder Return | 1.79% | 2.60% | 2.62% | 2.87% | -6.59% | 0.66% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.